MiMedx Group Inc (MDXG)

[mlkrborn]

good resuts $5.83 "MiMedx Group follow up study of DFU patients shows 94% of patients remained healed after nine to twelve months (MDXG) 5.70 +0.18 : Co announced that its study "Dehydrated Human Amnion/Chorion Membrane Allografts in Patients with Chronic Diabetic Foot Ulcers: A Long-term Follow-up Study" has been accepted for publication in Wound Medicine. This study is the long term follow-up from a previously completed randomized controlled trial (RCT) involving patients with diabetic foot ulcers (DFU). In this follow up study, the patients whose DFU wounds healed after treatment with EpiFix in the initial RCT and the subsequent crossover study were examined.

Eighteen of 22 eligible patients returned for follow-up examination, which was conducted 9 to 12 months after primary wound closure with EpiFix. Clinical record review was conducted with IRB approval and patient consent. Of the eighteen patients studied, only one patient had recurrent DFU during the follow-up period, while 17, or 94.4%, remained fully healed. These findings support the long-term effectiveness of dehydrated human amnion/chorion membrane ("dHACM") for treatment of DFU. The study concluded that dHACM is a clinically viable and economically feasible treatment option that should be considered by clinicians who treat diabetic pedal ulcers."